Vitamin D Binding Protein Antibody – Catalog number: B2010621 (0.1 mg)

Vitamin D Binding Protein Antibody (Catalog number B2010621) is supplied as a solution in a defined 0.1 mg amount with a specified concentration of 1 mg/mL. It targets human vitamin D binding protein (also known as GC protein) and is intended for use as a versatile molecular tool in research on vitamin D metabolism and in the development of vitamin D assays, consistent with the stated applications. Produced as a biotechnology-grade reagent—using Type I ultrapure water (>18 MΩ·cm) and 0.22 µm filtration—the antibody is designed for reliable, low-background performance when stored at −20 C as specified.

This reagent integrates readily into common immunological and biochemical workflows where DBP is a measurand, capture target, or control. The ready-to-use solution format removes reconstitution steps and supports straightforward titration and method setup across platforms such as ELISA development, blot detection workflows, and immunocapture procedures. Because DBP plays a central role in circulating vitamin D transport and binding, a dependable anti-DBP reagent is valuable for verifying assay conditions, benchmarking sensitivity/specificity, and supporting comparative studies in model systems or biofluids.

The clearly defined specifications (amount, concentration, storage) and biotechnology-grade preparation promote reproducibility across runs and lots. Labs standardizing DBP-related methods can leverage this antibody to streamline optimization, reduce variability, and maintain consistent signal characteristics in assay development and research use.

Why researchers choose this product:

• Defined 0.1 mg amount at 1 mg/mL concentration for straightforward assay setup
• Ready-to-use solution format; no reconstitution required
• Biotechnology-grade preparation (Type I water, 0.22 µm filtration)
• Specified storage at −20 C to support stability and reproducibility
• Aligned with stated use in vitamin D metabolism research and assay development

This product is for Research Use Only (RUO). It is not intended for diagnostic or therapeutic use.

References

• 41: Wang G, Li Y, Li L, Yu F, Cui L, Ba Y, Li W, Wang C. Association of the vitamin D binding protein polymorphisms with the risk of type 2 diabetes mellitus: a meta-analysis. BMJ Open. 2014 Nov 4;4(11):e005617.
• 42: Speeckaert MM, Speeckaert R, Delanghe JR. Genetic polymorphisms, vitamin D binding protein and vitamin D deficiency in COVID-19. Eur Respir J. 2021 May 6;57(5):2004638.
• 43: Cooke NE, McLeod JF, Wang XK, Ray K. Vitamin D binding protein: genomic structure, functional domains, and mRNA expression in tissues. J Steroid Biochem Mol Biol. 1991;40(4-6):787-93.
• 44: Pooyan S, Rahimi MH, Mollahosseini M, Khorrami-Nezhad L, Maghbooli Z, Mirzaei K. The Association between Vitamin D Deficiency and variants of Vitamin D Binding protein gene among Healthy Iranian Adults. Int J Vitam Nutr Res. 2020 Jun;90(3-4):249-256.
• 45: Tagliabue E, Raimondi S, Gandini S. Meta-analysis of vitamin D-binding protein and cancer risk. Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1758-65.
• 46: Norman AW, Ishizuka S, Okamura WH. Ligands for the vitamin D endocrine system: different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein. J Steroid Biochem Mol Biol. 2001 Jan-Mar;76(1-5):49-59.
• 47: Maghbooli Z, Omidifar A, Varzandi T, Salehnezhad T, Sahraian MA. Reduction in circulating vitamin D binding protein in patients with multiple sclerosis. BMC Neurol. 2021 Apr 20;21(1):168.
• 48: White P, Cooke N. The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab. 2000 Oct;11(8):320-7.
• 49: Navas-Nazario A, Li FY, Shabanova V, Weiss P, Cole DE, Carpenter TO, Bazzy-Asaad A. Effect of vitamin D-binding protein genotype on the development of asthma in children. Ann Allergy Asthma Immunol. 2014 Jun;112(6):519-24.
• 50: Badr B, Cassim S, Rehman R. Can low Vitamin D Binding Protein levels be a cause of infertility in females? J Pak Med Assoc. 2019 Jul;69(7):1064. pubmed.ncbi.nlm.nih.gov